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First-year medical students now can get a portion of their neural science education from
HyperBruin, a Macintosh-driven LaserDisc program in which the computer displays instruc
tions. diagrams and text, and the LaserDisc - titled " Slice of Life" - provides 50,000 high
definition images . Four complete stations are availublc in thc Media Computer Center in the
library, and students have the luxury of scheduling their own time for instruction . Lessons are
not nccessarily linear: "There ure muny ways in, and you can go forward. backward or
explore any subject in greater detail," says Ed Walter. media librarian. According to Thomas
A. Woolsey . M.D., course director, response to HyperBruin has been good . " In talking to
students, my impression is that they ure better prepared ," he says in support of the new
teaching tool incorporated in response to student enthusiasm .
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magine learning to
speak without knowin g
how words sound. That
is the challenge deaf chi Idren
face, one that takes inten sive
training to meet. Now, early
results of a stud y at the
Central In stitute for the Deaf
(CID) show that cochlear
implants may make the sk ill
of speakin g a little easie r fOI'
deaf children to acquire.
For three years, investiga
tors at CID measu red deaf
children ' s progress in
learnin g to speak and
understan din g speec h. Those
with cochlear im pla nts were
signi ficantly better at both
tasks than were children
using e ith er conve ntional

I

hearing aids or tactile aids,
which convert so und into
vibrations on the skin.
"We have no doubt that
auditory speech perception is
improved by a coc hlear
implant and that som e
aspects of speech production
are accelerat ed, " says Ann
Geers, Ph.D ., principal
investigator and director of
c lini ca l services at ClD. She
cautions, however, that th e
co nclusions are preliminary
because th e st ud y is not
comp lete. The researchers
have comp iled result s from
18 of 48 c hildren in the
study.
Only abo ut 10 percent of
profoundly deaf children in

The implantable portion of the cochlear implallt system
includes the internal receiver-stimlllator (at left) and the
electrode array (resembling coiled wire) that is threaded
throllgh the inner ear. The dark disk is a magnet that
cOllnects the implant to the transmitting coil that is worn
externally.
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this co untr y lea rn to talk,
Geers says, because few
have access to the intensive
tra ining and hi ghl y ski ll ed
teachers requi red . If th e
early findings hold, cochlear
implant s co uld make that
training less diffic ult and
therefore more accessible,
she says.
The study is the first to
compare the effects of
cochlear implants with other
device s by look in g at
children who are a ll in the
same educational program ,
says je,lI] Moog, co-investi
ga tor and principal of th e
CID schoo l. 'Tha t a llo ws us
to separate the effec ts of the
device from the effec ts of
training," s he says.
Cochlear implants pick up
sound throug h an external
microphone and rela y it to a
speech processor. The
processor tra nsm it s to a
decoder surgically implanted
in th e skull beh ind the ea r.
The decoder then stimulates
an array of e lectrodes
implanted in the ear's
coc h lea, and the e lec trodes
excite the auditory nerve.
Because the device canno t
reproduce as man y frequen
c ies as an ear , the sounds it
mak es are less clear than
normal hearing. "The
coc hlear implant is not
mak ing children hear the
way you and I hear, " Geers
says . "It's a whole new
sensation. Th ese children are
tryin g to learn language
based on very limited
info rmation. "
Of the 18 ch i1dren who
have finished one year or
more of th e stud y, all

showed roughl y equal
abilities to distinguish basic
speech patterns - heari ng
the difference between o ne-,
two- and three -syllab le
words. But on tests that
required percepti o n of
differen t sounds , implant
ch ildre n showed a marked
advantage, Geers says.
Children with, implants
also produced more under
sta ndable speech. In a test
that measured the number of
und ers tandable utteran ces
out of 50. the researc hers
found that implant children
impro ved by 45 percent,
compa red to about 10
perce nt for tacti Ie aid a nd
hearing aid chi Idren. "Th e
bottom lin e is how much of a
child's speech we can
understand . That appears to
be fairly dramatically
affected by th e implant,"
Geers says.
Alth ough cochlear
impl ant results look promis
ing, th e researchers intend to
finish th e st ud y befo re
making definite co nclu sions
about the implants' effects.
"We're intere sted in coch lea r
implants , and we're optimis 
tic, but we ' re not ye t ready
to begin recomme ndin g them
on a regular basis," Geers
exp lains.
"We believe that if deaf
children can learn to talk ,
they can be mOI-e indepen 
dent beca use th ey wo n' t
need an interpreter. It ope ns
up all kinds of socia l,
economic and work opport u
niti es if they can communi 
cate with anyo ne," Moo g
adds . •
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illiam A. Peck,
M .D., and Jo sh ua
R. Sanes, Ph .D .,

ha ve been honored wi th
election to the rank or fellow
by the American Association
I'or the Advancement or
Science (AAAS) . A fellow
of the as socia tion is defin ed
as a "membe r whose efforts

Peck is an internationall y
re cog ni/ed expert in the
study and treatment of
osteoporosis. a prog l-essive
bone di sease that is believed
to affect more than 20
mill ion A Ill erican s-usuall y
women-who su ffer bone
loss and w ho may have
severe skel ew l and health
problem s. His con tri but ions
to academic medicine
include clinic<J1 pati en t care,
research , teaching and
ad min istl'<J ti on .

synaps e formati on ." Hi s
research is directed towa rd
le<J rning how synapses form
in th e ve rt eb rate neuromus
cular system. His l ab is
invest igat ing w hat mol ecu les
neuro ns use to recogni 7.e
each other, leading to the
hi gh ly co mpl ex pattern s of
synaptic interconnecti o ns
that form during develop
ment.
Born in Buff<Jlo, San es
rec eive d bachelor's degrees
in biochemistry and psychol
ogy from Yale and a doc tor
ate in neurobiology I'rom
Harval'd. He joined Wash
ington University in Ino as
an assiswnt profe.<.,so r of
physiology and biophysics
and was named professor of
anat o my and neurobiology in
1988, •

Olin F(~ll()w~
1\'anu·<1
William A. Peck, M.D.
on behalf of the advance 
ment oj' scie nc e or ih
applications are sci en tifically
or sociall y distinguished."
Peck, vice chancellor for
medical affair s and dean of
the med ical sch ool and
pres ident of th e Washington
University M edical Ce nter,
was named for hi s "distin
guished research in bone and
mineral metabolism and for
leadership in developing an
interna tionall y acclaimed
cente r of c lini cal investiga
tion at Washin gton Univer
sit y."

Joshua R. Sanes, Ph.D.
A ll<Jtiv e of Co nne ctic ut ,
Peck is <J graduate of
Har v<Jrd Uni ve rsity , where
he ea rned his undergraduat e
degl'ee cum l<Jude in 1955 .
He received his mcdical
degree with honors from the
University of Rochester
School of M ed icin e in 1960.
He joined the Washington
Uni ve rsi ty f<Jculty in 1976 as
Simon Professor of Medi c ine
and physici<Jn-in-chief of th e
Jewish Hospital of SI. Loui s.
Scll1es was elect ed <JS a
fellow "for lll<Jny insights
into the mechanism 0 1'

he selection commit
tee for th e Spencer T.
and Ann W. Olin
Fellowships For M ed ical
Scientists recently an
nounced the names or'
fellows selected for 1991 .
According to Philip D. Sta hl ,
Ph .D., director of th e
Division or' Biology and

T

Biomedical Sciences, th e
W ashi ngt o n University
stude nts se lected <Jre:
Jumes F. Amatruda,
Robert Ari Berkowit z,
Sanjay A. D esa i, Mi chae l A.
Farrar, Robin D. Hanson,
Stanley L. Hazen, Andrew
D . Hershey, Gurjit Khurana
Hershey . Robert C. Piper,

Carlos Rosales, David A,
Rudnick, Bradle y L.
Schl agg al', David K. Simon,
Vivianna Derech in Van
Deerlin, James A. Waddle .
Peter We ster velt and
Andrew A. Zupan.
Re cogni/.e d for su peri or
achievement in biomedical
research, Olin Fellows look
fo rw ard to outstanding
careers in medicine. M os t
are engaged in pursuing
co mbined M.D '/Ph.D.
degrees and already have
gained national recognition
for their research.
The fellow ship s are
I'unded by a $30 milli on
commitment to the Divi sion
of Bi o logy and Biomedical
Sci ence s made in 1986 by
th e Spencer T. and Ann W.
Olin Foundation. The gift
suppo rt s stu dent s in th e
Medical Scientist Trainin g
Program ( MSTP) , The
MSTP comb in es a so lid
education in clinical ski ll s
wi th training in ba sic
res earc h techniques. The
program at Wa shin gto n
University School of
Medicine is the among the
nation' s most prominent ,
allracting you ng people of
exceptional talent from
around the wodd, Through
~upport

of th e program , the
fellowship s are instrumental
in helping to fill the continu
ing sh ortage of ph ysic ian s
who pursue careers in
biomedical re sea rch.
Th e gift also supports an
annual Olin Symposium that
focuses o n biomedical
research and ass ists in th e
training of student s in the
M.D '/ Ph .D. prog ram, •
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ru gs called NMDA
antagonists can
prevent brain damage
caused by stroke, but the y
ha ve not been used for that
purpose beca use of tox ic
side effects. No w it may be
possible to block tho se side
effects, thereby allowing
doctors to use NMDA
antagonists to prevent stroke
damage, say scientists here.
The team's paper in the
journal Sci(,lIc(' reports that
scopolamine - a drug used
widely as a motion sickness
remedy - is one of several
drugs that prev e nt the toxic
side effects of NMDA
antagoni sts , thereby maki ng
them safe r for use in stroke
therapy.
"Thi s is a fascinating line
of resea rc h," says aut hor
John W , Olney, M.D ..
professor of psychiatry , " that
has take n seve ral surpris in g
turns." Amo ng the NMDA
antagonists that O lney and
his collea gues ha ve been
studying, the best known is
phencyclidin e (PCP), also
called "ange l dust." Neuro
scientists were sur prised to
find in th e early 1980s that
PCP, an ill ega l street dl'ug
that causes psychotic
sy mptOIllS , can powerfully
protect the brain agains t
stroke.
Then , in 1989, O lney and
hi s co ll abo rators repo rted

D
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th at PCP and re lated dr ugs,
in addition to protecting
Illan y nerve ce ll s against
stroke damage, also have a
neuro tox ic action th at
damages some nerve ce lls.
And now O lney an d hi s
co ll eagues have found that
the neurotoxic act ion can be
elimi nated by several
common drugs, such as
scopo lam i ne and
pentobarbital.
These new findings raise
an important question: Can
the drugs th nt prevent th e
neurotoxic side dfec ts also
prevent th e psyc ho ti c side
effects') "There is indirect
evidence providing a basis
for optimism on this point,"
O lney says. " However, the
final answe r to thiS question
must await future human
studies beca us e the expres
sion of psyc hotic symptoms
is a peculiarly human trait."
C urrent ly, no effective
treatment to limit brain
damage ca used by st roke
ex ists. Acco rdin g to th e
Nati o nal In stitutes of Health ,
stroke is the third leadin g
cause of death in the United
Sta tes. Of the 500,000
A me ri ca ns who su ffer a
stroke each year, nearly 10
percent die and 20 to ]0
percent are permanently
disabled. Olney is hopeful
that this research will
facilitate the development of
effecti ve and safe treatm e nt s
for stroke, but he cautions
that extensive clinical trials
will be needed before such
treatments can become
gene rall y available.
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ne of two newly
li censed vaccines
used to protect
infant s from bacterial
meningitis produces antibod
ies th at are less effective at
binding to lhe surface of
bacteria, say sc ie nti sts at the
medical sc hoo l.
St ud y of th e vacci nes,
Hi bT IT ER, PedvaxHIB, a nd
PR P-T, shows th at th oug h
e<lch vacc in e produces
enough ant ibod ies to prevent
Hilfll10jJhiills iI1111l(,11~({e type
b (Hib) infectio n.
Pedvax HIB, prepared by
Merck Sharp & Dohme.
produces antibodies that bind
to the bacterial polysaccha
rid e capsu le les s avidly than
antibod ies e licited by the
other Hi b vacc ines.

Randy L. Farmer has been
appo inted assistant vice
c hance llor and director of
medical alumni and de velop
ment programs, according to
an announcement by David
T. Blasingame, vice chancel
lo r fo r alumni and develop
ment programs.
Farmer came to Washing
ton University in 1988,
joining the office of corpo
rate and foundation relations.
He was named direc tor of
that offi ce in 1989 . •

The results, reponed in
the j ourl/ol of llie Arnl:'ricoll
M l:'dicoi Associotioll, may be
important in the assessment
of the effectiveness of oth er
new vaccines, says Dan M.
Granoff, M.D., professor of
pediatrics and director of the
division or' infectious
diseases.
In the study, Granoff and
his colleagues analy zed 171
blood samples taken from
c hildren vaccinated for
f-fo cmojJhiills il1flucl1 aJC type
b ( Hib J, a leading cause of
b<lcterial meningitis, seps Is
and pneu monia. T he g ro up
te sted two vaccines licensed
for use In infnnts:
HibT ITER, prepared by
Praxis Biologics/Lederie a nd
PedvaxHIB , prepared by
Merck Sharp & Dohme, and
a third vaccine for older
childl-en, PRP-T, prepared by
Me ri eux In sti tu te in Lyon,
France and cUITent ly
awaitIng licensure In the
United States

Although both the Pra xis
an d Merck vacc ines protec t
ag ainst bacterial meningitis ,
the vaccines achieve protec
tion in fun dament ally
differe nt ways. After a sin gle
injection of the Merck
vaccine, two- mo nth-old
infants elicit high antibod y
concentrations , which are
enough to protect the m,
Gran off says. Th e Praxis
vacc in e may require two or
three inj ec tions to fully
prot ec t an infant. "Children
wh o get the Prax is vaccin e
are not fully protected until
after six or seven month s of
age," Gra noff says. "The
Merc k vaccine achieves
protection in a single dose at
two month s."
But Granoff say s there is
a price for th e speedy
antibody res ponse elici ted by
the Merck vaccin e. "The
overall quality of th e
antibody achi eved by the
Me rck vaccin e at seven
months is infe rior to th at
elicited by the Praxi s
vaccine," GranoFF says. The
diffe re nc e relat es to the
Me rck antibody's decreased
ability to bind to the bact e
ri al surface and initi ate th e
process hy which oth er
protein s in the blood kill
bacteri a.
By measurin g a ntibody
avidity . or how we ll an
antibody bind s to antige n,
Granoff ha s shown th at it
takes alm os t seven times
more antibody elicited by the
Merck vaccine to kill
bacte ria. GranofF say s thes e
re sults do not indicate th at
Merc k's vaccine is infe rior.
"The point is that the
vaccines elicit much hi gher

antibody concentrations in
most children tha n required
tor killing th e bacteria," he
says. "The fact that it takes
seven times more antibody
doesn't really matt er as long
as the antibody concentra
ti ons are surficient."
The Merck vaccine.
Granoff not es, has an
advantage if a baby is at high
risk of disease, lik e th ose
who att end day care or have
older siblings. "The advan
tage of protectin g an infant
with a sing le. ea rly injecti on
is considerabl e." he say s.
"O n the other hand , if a baby
is not at hi gh risk for being
exposed to infecti on, then
the other vaccines that
induce a highe r aFfinity
antibody might be more
desirable. Ultimately, Ithink
all three vacc ines will be
effectiv e."
Granoff beli eves the
study should intlu ence how
vaccine s are tested in th e
fUlL1re. Traditionally.
sc ientist s hav e monitored a
vaccine's effectiveness by
measurin g how much
anti body is produced. Ifa
new vaccine produces as
much antibody as an old
vaccine, it has been con sid
e red equival e nt to the o ld
vaccine. These studies
ne glect the avidity of the
antibody, Gran off says. "1
think we need to be at least
thinking about whether
measuring total antibody
concentrations is sufficient
or wh eth er other meas ure
ments, such as antibody
avidity . should be added to
the vaccine eva luation
process."
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ee N. Robin s, Ph .D ..
professor of soc ial
sc ie nce in psychiatry
and director of the Masters
Progra m in Psyc hiatric
Epidemiol ogy. has bee n
named University Professor
of the Soci al Sciences at the
university , Chancellor
William H. Danforth has
announced .
University professorships
are held by di stinguished
scho lars whose work
overlaps di sc iplines and
schools. In her new ro le,
Robin s will continue her
respo ns ibiliti es at the School
of Medicine a nd will play an
ex tensive ro le within th e
Fac ulty of Arts and Sciences.
"Robins is on e of the
most di stingui shed social
sc ienti sts associated with
Washington University,"
notes Martin H. Israel, dea n
o f the Faculty of Art s and
Sciences . "As Univers ity
Professo r and a me mber of
th e ne wly form ed Commillee
on Social Thou ght and
An alysis, she will playa
s ignificant role in shaping
the soc ia.1 sc iences curricu
lum at th e uni versit y."
Th e Commillee on Social
Th ought and An aly sis was
created earlier th is year to
supervise a n interdiscipli
nary curriculum that draws
on facult y from various
departme nt s in th e social
sciences, humaniti es and th e

L
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engi neering, law and socia l
work sch oo ls.
Robin s, who is interna
tionally recogni zed as a
lead er in studi es of behav
iora l disorde rs in chi Idre n,

Lee N. Robins, Ph.D.
ha s bee n a me mbe r of the
School of Medi ci ne faculty
since 1954 . While establish
ing her profes sional ca reer in
sociology and epid e miology
in th e psyc hiatry depa rtment,
she has held adjunct appoint
me nt s in the soc iology
department a nd the In stitute
for Urban ancl Regional
Studies on the Hilltop
Campu s. Much of Robins'
work has centered on the
effec ts of dru g use, alcohol
ism and other familial
disorders on child develop
ment. •
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esearch here has
identihed the first
genetic marker fo r
no n-in sul in-dependent
diabete s, a di sease that
affects million s of Ameri
ca ns.
In ves tiga tors studi ed
ge neti c pattern s in 16 Fre nc h
families in whi ch so me
members had a for m of noni nsul in-dependent diabetes,
also called Type" diabetes.
They found that about ha lf of
the diabetics inh erited a
particular form of th e
glucokinase gen e. Glu cok i
nase is an enzyme criti ca l for
stimulating the produ cti on of
insulin , the chem ical that
allows gluco se to en ter body
ce ll s.
" We have show n that a
perso n is more like ly to
inherit a specifi c form of th e
glucokinase ge ne if th ey
ha ve one kind of Type "
diabetes ," says MAl an
Permutt, M.D., professor of
medicine in the division of
metabolism. "Although we
studied a subset of Type [[
diabetics, we think the
results may app ly to all Type
" diabeti cs."
The resu lt s stro ngly
sugges t th at a mutatio n in
the glucokinase ge ne could
contribute to ca usin g Type "
diabetes, but th e in vest iga
tors have no t ye t id entifi ed
th e defec t Itself, Permutt
says. The fi nd in gs co uld lead
to tes ts usin g thi s gene as a

R
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marker to predi ct di abete s
and, wi th furthe r understand
ing of the ge ne ti c influences,
co uld eve ntuall y lead to gene
therapies.
Type I diabetes, or
insul in-de pe nde nt diabetes,
is usually diagnosed in
childh ood. It is caused by an
inability to produce adequate
amounts o f In sulin. Type"
diabetes is the more common
form a nd no rmall y appears
111 middle age. It s cause is
unkn ow n, but o bes ity and
ge neti c influences ha ve been
identifi ed as ri sk factors. Th e
diabeti cs In Pe rmutt 's stud y
had a particular kind of Type
II diabetes, distinguished by
patients who first showed
sy mptoms before age 25.
Researchers have
searched for genetic marke rs
for Type" diabetes for
years. But the task has bee n
diffi cult because the disease
is probabl y caused by many
ge nes. "This is step number
one in unco verin g what
ca uses T ype" di abet es. One
importance of the findin g is
that it indicates th at thi s
approach of stud y in g
candidate genes is going to
payoff," Permutt says. "This
will be encourag in g to oth e r
scientists working in this
field."
The next step, he says, is
to find the mut ati o n involved
and find out how frequently
the mutati o n occ urs in the
ge neral po pulati on of T ype
" diabeti cs . " We'd like to be
able to iso lat e the ge ne a nd
then show that it ma kes a
defecti ve e nzy me," he says.
The stud y appea red in the
March 12 issue of Nal ure . •
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usan Crawford, Ph .D ..
professor of bi omedical
communlcalion and
direc tor of th e Library and
Bi o medi cal Com munications
Center, has received the
Presi de nt 's A ward and the
Marc ia C. Noyes Award of
the Med ica l Library Associ a
ti o n (M LA )

S

libraries on both the national
and inte rnati o nal leve ls.
Crawford has authored or
edited more than 120
publication s and ha s re
ceived man y national ho nors
for her wo rk . Durin g her I 1
year tenure at Washing to n
University, she has bee n
instrumental In pl a nnin g and
funding the medi ca l sc hoo l' s
new Library and Bi omedi cal
Communic ations Center.
ThIS hi ghly automated center
hous es one of the most
di st in gui shed medical
collections in the co untr y . •
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Susan Crawford, Ph.D.
The Pre sident 's Award is
give n annuall y to an indi
vidual who ha s made
exce ptional contributi ons
that have enhanced the
profession. The Noy es
Award, the associati o n's
highest honor, recogni zes an
individual who has mad e
lasting and outstandin g
achievements. Th e awards
c ite Crawford's " uni versa l
co ntribution s to the profes
s ion in the areas of se rvice ,
research , and publi shing"
that ha ve given stature and
credibility to hea lth sc iences

he School of
Med icin e's Executive
Fac ulty has voted to
provid e as much as $80,000
to co ntinu e funding th e
Summer Medical Student
Resea rch Fellows hip
Program that rece ntly was
placed at ri sk by a loss of
the Basic Research Science
Grant (BRSG) from the
Publi c Health Service - the
program ' s principal suppo rt .
According to Milton J.
Schlesinger, Ph.D. , profe ssor
of molecular microbiology
and administrator of th e
fellowsh ips for the past
se ven years, the summer
prog ram provides first-year
students with an opportunity
fo r hands-on experienc e in a
research lab and dire ct
co ntac t with a fac ulty
member early in their
medi ca l sc hool careers.

"Thi s decisi on by th e
Exec uti ve Fac ulty show s th<lt
they be li eve the program to
be esse nti al to both edu ca 
t ion a nd rese arc h he re as
well as to steerin g young
careers, " Schl es in ge r says.
Until th e rece nt NIH
bud ge t cut in th e BRSG , the
program ma naged to
accommodat e al mos t a II
stud ents applyi ng fo r
summer fellow s hips - the
res t were sup port ed by NIH
traini ng grants or other
medi ca l sc hoo l funds. That
meant 36 student s engaged
in resea rch in laborator ies
he re during the summer of
199 1. Each rece iv ed a
$ 1,800 stipend and produ ced
a written re port of the
expe ri e nce. Some saw th eir
n<l mes on publi s hed papers,
and <l fe w had a di rec ti o n set
for th eir life' s work.
In 1992, Sc hles inger says ,
only enough mone y was
goin g to be a va ilable to fund
a max imum o f 10 fell ow
ships. Public Hea lth Service
fund s for such gra nt s have
been redu ced across the
board and are be ing divid ed
amon g a grea te r number o f
prog rams, he expl ain s.
But th e n the Executi ve
Facult y rescued th e program.
Most of the fundin g now will
come fro m the medical
school 's de partments unde r a
formul a we ighted fo r th e
num ber o f students parti ci
patin g and the departme nt s'
ind ividu al abiliti es to pa y.
As a result, Sc hl es inger says,
it will be poss ibl e to accom 
modate all 39 applicants o n
fil e with a $2,000 stipe nd fo r
their 1992 summ er researc h
prog ra ms . •

rr'H)

A,nll·(I~.,

IIullor 'fo Hai...hlf'"

eurolog ist Marcus E.
Ralc hle, M.D., I S th e
reci pient of two
awards for hi s gro un d
breaking resea rc h on the
function of the hu ma n brain.
He also has bee n e lected to
the pres ti g ious In stitut e o f
Medi cin e of the Nati o na l
Acade my o f Sciences.
One o f 50 new members
o f the institute, Raic hle
in vesti gat es how the brain
perform s daily tasks. He
<lims to crea te a brai n atl as
th at ma ps regions of th e
brain res pon sibl e fo r suc h
functions as la nguage and
attention.
Rai c hl e was present ed
wi th the 1992 Decade of the
Brai n Medal by th e Am eri
ca n Assoc iati on of Neuro-

N

The 1992 Decade o/the
Brain Medal presented to
Marcus E. Raichle, M.D.
logi ca l Surgeon s on April 13
at the group ' s annual
meetin g in Sa n Franci sco.
Th e medal commemora tes

the " Decade of th e Brain
1990-2000," enact ed by
Cong ress to enh ance pu bli c
aware ness of the be nefits o f
brain resea rch. The medal is
aw arded annua ll y to a
di stin gu ished neurosc ienti st
in recog nition of notabl e
co ntributi ons to thi s re
search.
He al so rece ived the
Silvio O . Co nte Decade of
the Bra in Aw ard from the
Natio nal Foundati on for
Brain Research at th e
organ ization 's third annual
Decade of th e Brain Sympo 
sium on May 19 at the
Nati onal Press Club ill
Was hington, D.C. The
fo unda tion present s th e
award annu a lly to a pe rso n
who has demonstrated
leadershi p and exce llence in
the adv ance men t of the brain
sc iences . •

yrnposium Explores Project L.uJ1lications
A Marc h 24th symposium
sponsored by the Program
for Women in Science in
Medic ine featured three
women experts as speakers
on the topi c: "The Genom e
Initiative : Recent Advan ces
and Implications for Hum an
Health Care." Helen Donis
Keller, Ph.D., who hold s an
appointment in ge netics and
psychiatry here, discussed
the overall scie ntific goal s of
the fed era lly-spon sored
Gen ome Initiative a nd
reported on progress in her
laboratory. Mary-Claire
King, Ph .D., pro fes sor in the
School o f Publi c Health,

University of California,
Berkeley, described epide
miologica l and genetic
mappi ng approach es for
pioneerin g famil y studies on
genetic factors in breast
cancer. And Patric ia Kin g,
J .0 .. pro fe ssor of law at
Georgetown Universit y Law
School di scu ssed the social
and ethi cal implication s of
mapping th e hum an genome.
"Thi s is the first time in our
hi story th at the government
ha s undertaken to expl ore
such impli cations at the
sa me time basic sc ienti fic
studies are under way," she
noted . •

Mary-Claire King, Ph.D.
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A New Drug Limits Bone

era
Damage In Kidney Disease
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he 20 million Americans affected by
kidney disease face a number of related
hazard s including hypertension, severe
anemia and the toxic effects of waste
products that builcl up when kidneys fail.
But one of the most serious complications
associated with chronic kidney disease,
es pec ially in patients maintained on
chronic hemodial ysis, is secondary
hyperparathyroidi sm - a condition that
can res ult in bones so brittl e th at they snap
with one miscalculated step.
Secondary hyperparathyroidi sm occurs
when calcium levels in the blood fall
below normal ancl cause an inc rease in
ac tivit y of the parathyroid gland, which
produces parathyroid hormone (PTH).
Overproduction of PTH causes mineral
metaboli sm to go awry , robbing calcium
from bones to maintain ca lcium leve ls in
the blood. The result is the paInful and
debilitating bone di sease os teo itis fibrosa,
which makes bones brittl e.
This complication, whi ch also increases
risk for kidney stones, os teoporosis and
gastrointestinal problems , has baffled
researchers for decades. But after 30 years
of work , a promi sing new compound may
be able to re verse secondary
hyperparathyroidi sm and minimize
damage done to bone .
When calcium leve ls in the blood drop
even minutely, se nsors in the parathyroid
glands located at the base of the neck
respond immedi ately by sec retIng PTH.
The hormone binds to bone ce ll receptors
known as osteoblasts, which send a
message to the resorblllg ce ll s, osteoclasts,
and calcium returns to the blood.
"The secretion of PTH is a protective
response that mobili zes calcium from the
bone to normali ze calcium in the blood:'
says Eduardo Slatopolsky, M.D., Joseph
Friedman Professor of Renal Diseases in
Medicine. "But there is a price to pay ,
because overproduction of PTH causes
further destruction of the skeleton . The
bones become brittle and break, and they
don't heal well because the bone is
abnormal. "
Slatopolsky, who has spent his career
studying secondary hyperparathyroidism,
currently is investigating a compound he
says may be key in reversing the devastat
ing condition. The compound, called 22
oxacalcitriol (OCT) was developed in
Japan and is an analog of vitamin D, which
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Eduardo Sta/opalsky, M.D., Joseph Friedman Professor of Renat Diseases in
Medic ine, studies secondary hyperparathyroidism. His investigations have identified
a compolllld that may reverse the couditioll.

controls the metabo li sm of ca lcium and
phosphorus in rhc body. OCT acts in a
manner sim ilar to that of th e active
component or vitil min D, called caJcitriol,
that inhibits production of PTH and
contro ls the severity of secondary hyper
parathyroidism.
In anima l studies comparing OCT ilnd
calci tri oL Slatopolsky says OCT appears to
have a II the benefits of calcitri ol but none
of its negative side effects. In some
patients with secondary hyperpara
thyroidism, calcitri ol can cause
hyperca lcemia (high ca lcium in the blood ),
metastatic calc i ficat ions or occ Iusion of the
coronilry and peripheral arteries , gangre ne
and eventually loss of extremities.
"We can giv e very large doses of OCT
to suppress PTH secretion and the effect

on calcium metabolism is minimill , next to
nothing," says Slatopolsky. "We are trying
to develop clinical protoco ls to see if we
actually wi II be able to suppress PTH in
human s. If so. this probably will be thc
drug of ciloice.·'
Slatopolsky's teilm has used OCT
success full y lO rev erse seco ndary
hyperparath yroidism in uremic dogs and
rats. He anticipates similar expe riments
usin g OCT in humans later thi s year in
Japan. where the developer of OCT,
Chugai Pharmaceu tical s, is located.
Chugai and Washington Univers ity
have patented the OCT compound, and
Slatopolsky has receiv ed a $500,000 grant
from the compa ny to conduct further
investigiltions on how various organs 01'
the body metabolizc the vitamin D

derivative. Currently, his laboratory is
studying how ca lcitri o l and OCT suppress
the synthesis and sec retion of parathyroid
hormone on the molecular leve l. Alex
Brown , Ph.D., assislClnt resemch professor
in medicine, and Jane Finch. research
associate , are conducting a series of
experiments in rats wi th kidney failure to
understand the mechanisms by which OCT
suppresses secondary hyperpara
thyroidism.
Slatopolsky says OCT succeeds where
calcitriol fai Is because it is metabol ized
differently by diffe ren t organs of the body.
spec ifically the gastrointestinal tract and
ske letal system. Bot h ca lcitriol and OCT
bind to receptors in the parathyroid gland
and suppress the synthesis and secreti on of
PTH. But in the intestine ,Ind in bone,
where th ere are also receptors for ca lcitriol ,
there is virtually no response produced by
OCT.
" In the parathyroid g lands, OCT is
equal to ca lci triol, but in th e intestine its
action is minimal," Slatopo lsky says. "It
depends on the site we're talking about
whether it's more active. equally active or
less active than cilJci tri o l. There are a lot of
unknowns that we don ' t understand."
Slatopolsky ' s work hilS been in strum en
tal in defining specific aspects of renal
failure and developing bedside th erilpies
to treat it. H e is recogn ized as a leacler in
the study of mineral metabolism in
patients with chronic renal failure. [n
1982, he was the first to begin intravenous
use of ca lcitriol in conjunction w ith renal
dialysis to suppress secretion of PTH.
Until then , calcitriol had been given orally
in small doses. Although oral doses
increased calcium absorption, they weren ' t
enough to control the production of PTH.
" Wh en you have renal fai lure, the
number of receptors for calcitriol in the
parath yro id gland drops," Sliltopolsky
says. "B ut with higher concentrations of
calc itriol. which we achieve through
intravenous infusion, we can I'egulate the
number of receptors, and the effect of
calcitriol is magnified for improved
suppression of PTH."
When renal t'ailure plays havoc with the
ab ility of individLwl parathyroid ce ll s to
recognize calcium. it is referred to as a
"s hift in set point." As a res ult,
SJatopolsky says. hi gher blood calcium
concentrations must be present for the
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111 Slalopolsky's lab, Alex Brown. Ph.D. , prepares samples for an assay.

parathyroid cells' sensiti ve secretion
mechanism to recogni ze ca lcium the way
normal cells do.
"The sensitive mechanism we have (to
recognize calcium) is lost to renal failure,"
he says. 'The number of receptors drops.
the set poi nt is shifted to the ri ght . and
there is a blunting effect that causes yo u to
need much more calc ium . We can return
the set point to normal because the
abnormal set po int. in part, is due to the
lack of calcitriol."
Still. there is a limit to how far calcium
levels can be in creased without causing
adverse effect. Disease (such as metastatic

10

calc ifi catio n or hypertension) or symptoms
(such as headache. nausea and vomiting)
can result when calcium levels soar too
hi gh and ot her mineral levels, such as
phosphorus, are left unchecked.
Early in his career, Slatopol sky showed
that the phosphol1ls retained by patients
with renal failure play s a significant role in
the development of secondary
hyperparat hyro idi sm and resulting bone
disease. With kidney disease, the body
loses its ability to rid itself of the phospho
rus normally eliminated throug h urine.
Phosphorus, a mineral we consume in our
diets daily, impairs the metabolism of

vitamin D by suppress in g the action of the
enzyme, I hydroxylase, responsible for
converting vitam in D into calcitriol.
In the past. phosphorus levels were
controlled with diet and with aluminum
based phosphate binders, otherwise known
as stomach an tacids. which trapped the
phosphorus and allowed its remov al
through excret ion. Problems developed
when researchers discovered that patients
with kidney failure retained aluminum in
the bones. Aluminum retention can lead to
the painful bone disease osteomalacia and
can cause death from aluminum enceph
alopathy .
Aluminum-based phosphate binders
have since been replaced with ca lc ium
carbonate that eliminates phosphorus from
the body but also substantially increases
ca lci um levels. The problem. SJatopol sky
says. is that with the increased calcium
le vels patients can't tolerate suffi cien t
doses of calcitriol to suppress PTH .
Slatopolsky's experiments with OCT
began about three years ago after its
companion compound . calcitriol . was
found to be effective in differentiating
malignant cells and in suppress ing the
abnormal growth of ski n fibroblasts.
Slatopolsky was hopeful that OCT would
work similarly on abnomlal parathyroid
ce lls, so he went to Japan to req ues t the
compound for testing.
Slatopolsky says OCT is one of the
most promising of about 50 vitamin D
analogs being studied worldwide in the
search for effec tive suppressors of
parathyroid homlo ne. Also exc iting is
OCT's potential for treating malignancies
and ski n disease. Studies in Japan have
shown that OCT reduced breast tumor
cells in rats by 60 perce nt. When used in
combination with a commo n form of
chemotherapy, tumor ce ll reduction was
even more dramatic. "This has the potential
to open new hori zons for treatment of
cancer, becau se it supp resses cell growth
and induces cell differentiation," says
Slatopolsky, who looks fo rward to
exploring the many possibilities presented
by what mi ght become med icine 's next
multi-purpose drug.

- - - - - - - - - - - - .-.

--- _§EiE
---- -
----- --- - 
---- ~
~ =
_

-- -- ~

-~

....
1

-

The Search For A Speedy AndAccurate
Assay To Diagnose HeartAttacks
try Juli Leistner
very year, millions of Americans
feel the fri ghtening symptoms of
a possible hea n attack: crushing
ches t pain, sweat in g, nausea. For
1.5 million, the sy mptoms are a
sign of the real thing. Half a
million o f them will die from their
hea rt attac ks.
Physicians have a well
eq uipped arsenal of treatments for
the nation's number-one killer, but in the
criti ca l early hours of an attack, they still
must rely on judgment to di stinguish false
alarms from hearts in trouble. For two
decades, ph ysicians have tested for the
appearance of a particular blood enzyme as
a sure sign of hean damage. But the
enzym e appears later, often only after the
time window during which treatment must
beg in to minimize damage. Researchers
are now sharpening their analytical skills
to find earlier markers. Soon they may
have easy, fast tests to diagnose within an
hour and even help monitor the effective
ness of treat ments.
When patients come to the hospital
emergency room with the classic symp
tom s, a heart attack may seem unmistak
able. But making a positive diagnosis is
not always easy: Characteristic chest pain
can be caused by indigestion: 40 percent of
heart attacks escape discovery from
electrocardiograms, and some pati ents with
abnormal EKGs have healthy heans. The
result : About four in 10 patients are
difficult to diagnose, says Paul Eisenberg,
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SLides treated with the capture antibody
((Conan" are exposed to pLasma from
patients. After a reagent is added, the
machine compares the resulting
fluorescence to a standard stored in
memory.
M.D., assistant professor of medicine and
director of the Cardiac Care Unit at Bame s
Hospital.
Since the 1950s, physici ans have sough t
help from tests for enzymes such as
transaminase and lactate dehydrogenase,
known to be released into th e blood after
hean attacks. But elevations did not occur
for as long as 48 hours and often were not
"specifi c" to - or consistently attributable
to - heart damage . Then in the early
1970s, Was hington UniverSity researchers
Burton Sobel, MD. , and Robert Roberts,
M.D ., found a way to quantify the enzyme
MB creatine kinase, which beca me the
cornerstone of diagnosis.

As the heart is choked of oxygen.
creatine k.inase, or CK, leaks out of dying
heart ce lls and into the bloodstream. Sobel,
now director of cardiology and Tobias and
Hort ense Lewin Distinguished Professor in
Cardiovascular Disease, and Roberts,
cUiTentiy head of cardiology at Baylor
University, recognized that one form of the
enzy me  MB CK - is derived almost
excl usively from heart tissue and that
ri sin g blood levels were therefore a reliable
sign of hean damage.
Sobel and Roberts developed assays for
MB CK that gradually became the
standard for diagnosing hean attacks, says
Allan Jaffe. M.D .. professor of medicine
and director of cardiac inten sive care at
Bames. But the original tests were
cumbersome and time consuming.
Then in the mid-1980s, Jack Ladenso n,
Ph.D., professor of medicine and pathol
ogy, developed a monoclonal antibody that
recognized MB CK. The findin g was
destined to make testing for MB CK
clinically practical , because monoclonal
antibodies lend themselves to fast.
automated analytical tests. The uni versi ty
licensed the monoclonal technology to
several companies, and automated tests
have since become available.
"When you use the antibody that
Ladenson developed, inaccuraci es that
occur with some other assays and could
lead to confusion ;n their interpretation
essentially don't occur. And it is much
faster than the old test," Eisenberg says.

\I

.lack Ladenson, Ph.D., (seated) and his colleagues developed the monoclonal antibody that was destined to make possible the
fa st, automated distinction between real heart attacks and false alarms. Ladensoll is shown in frol/t of the immunoassay ana
lyzer that performs the test. With him are (left to right): Yvonne Landt, research assistant; Sharon Porter, research technician,
and Geza Bodor, M.D., post-doctoral fellow. Not piclured is colleague Emad Daoud, M.D., Ph.D., also a post-docloralfellow.
Ladenson's lab staff gave the new
antibody a name they considered worthy of
its powerful potential : "Conan," after
Arnold Schwarzenegger's hulking film
character.
The commercial tests take pl<lce in a
machine roughly the size of a microwave
oven. An automated aml places a drop of
serum on a paper slide coated with Conan.
MB CK in the serum binds to Conan and
stic ks to the paper. The mach me flush es
the slide with a solution containing a
second, label-can-ying antibody . Another
flush adds a tluorescent marker to the label
that the machine reads to produce a
meas urement of MB CK. Eisenberg
estimates that about half the hospitals in
the United States now use automated
assays. He expects most to incorporate
them within a few years.
Although Conan is a significant
adva nce, problems remain. Besides heart
attacks, elevated MB CK sometimes also
results from hypothyroidism, renal failure,
and diseases invo.lving chronic muscle
damage .
12

But, says Eisenberg, " the major
limitation with MB CK is physiological: It
takes several hours for it to leak. out of
your heart mu sc le and into the blood in a
high enough concentration to measure. So
even if you had the fastest assay in the
world for MB CK, it' s not going to permit
diagnosis of a heart attack immediately."
At the same time , CUITent treatments such
as clot-busting thrombolytic drugs hinge
on treating patients as soon as possible and
within one to four hours of the start of an
attack .
"So you are stuck with a bit of a
dilemma: The test that will confirm a heart
attack generally becomes positive only
after you would want to start therapy, "
Eisenberg says. That's a dilemma worth
avoiding because thrombolyt ic therapy
carries an unavoidable but neve rtheless
acceptable risk of bleeding, according to
Jaffe.
As a result , Conan is used primarily as a
confirmation and to guide the later stages
of care rather than to help decide on the
initial care. For patients whose symptoms

are not clear cut, emergency room
physicians must decide two thin gs, Jaffe
says: "Who can you send home, and if you
decide to admit a patient into the hospitaL
what level of care doe s that patient need')
At present, people still use their best
judgment about how to do that."
Researchers are now using the Conan
strategy as a model to come up with e ven
better markers, says Dana Abendschein,
Ph.D., a researc h associate professor of
medicine in the cardiology division.
Abendschein, Sobel and Jaffe are
testing for sister fonns of M B CK 
called MM CK "i so forms" - to diagnose
heart attacks eve n earlier, perhaps within
one or two hours. The MM CK " tissue
isoform" leak.s from dead heart cells into
the bloodstream, where subtle chemical
changes occur to create two additional
isoforms. Abendschein and his colleagues
find that level~ of the tissue form rise
quickly in relation to the other forms
during the early stages of heart attacks. A
recent study found the rise a reliable
marker for heart attack in 95 percent of 50

l --··.
pati ent s. MM CK 's limitation is that it IS
not spec i fic to hean damage becau se it ca n
come from ti ssues other than hean muscl e.
The W a~ hin g ton University research ers
also are using th e MM CK isoform tests to
determi ne when clot-busting drugs have
opened blocked coronary aneries. "When
we give one of the clot-dissolving agents
like t-PA or streptokinase, we currently
have no way of knowing whet her the
blood clot dissolved exce pt by doing an
angiogram," Eisenberg says.
When blood now is restored, a /l ood of
enzy mes washes out. By measuring th e
rate of appea rance of the tissue form , Jaffe,
Abencl sc hein and Sobe l have found that
th ey ca n detect reo pen ing of the hean
artery wi th in an hour of the onset of
treatm ent 90 perce nt of the time.
Abend schein directs a core laboratory for
th e multi ce nrer Thrombolysis in Myocar
dial In fa rctio n (TlMI ) clinical trial, which
is investi gating th e utility of isoform
analysis for rapid diagnos is of coronary
reopening in pati ents gi ven clot-dissolving
dru gs.
Another possibility for fast diagnosis
and detec tin g reopening of aneries is
myog lob in, a protein involved in muscle

co ntraction. It also leaks from uamaged
hean tis sue very early. Ladenson has made
a monoclonal antibody for myoglob in th at
is th e basis of another automated assay ,
now close to commercial rel ease. Studi es
so far show myoglobin to be help ful but
slightly less accu rate than other tests.
However, it is also cleared from blood so
quick ly that it is useful only in pati ents
who get to the hospital ri ght away,
Eisenbe rg says . In add iti on, the protein is
not specific to heart damage.
On the other end of the time scale, th e
protein rroponi n, a structural part of musc le
ce ll s, leaks into blood over a peri od of
clays. Ladenson has made an antibody for
one type of troponin that he thinks may be
specific to th e heart. The assay now under
developme nt would be useful in patients
who co me in for treatment extremely late,
he says. C lini ca l tests on troponin are ju st
startin g.
'Troponi n mi ght be an impona nt test
w hen you have a fal se positive MB CK .
That' s a small ponion of patients, but it
represents a diagnos tic problem w hen it
comes up. Hav in g so mething else that's
very cardiac spec ifi c would be helpful
th ere," says Eisenberg.

Plasma from a patient suspected of
having suffered a heart a11ack is loaded
into a vial, then sampled by the immu
lIoa ssay analyzer.

The researchers predict that physi cians
will eventually use a combination of th ese
tests. " As the testing becomes more
readily available and rapid, it might
eve ntuall y be possible to take a small tube
of blood and do a battery of te sts. W e are
already beginn ing to look at com binati ons
of markers considered together,"
Abendschein says.
B edside diagnos is with one, quick
bl ood test is the ultimate goa l, Eisenberg
says. " At the same time, we'd like to have
somethin g th at's 100 perce nt cardiac
speci fi c. None of th ese CUITent tests is
pelt'ect. All of th em still require an element
of clini cal Judgment."
Rapid assays, Eisenberg predicts,
probably will not guide the initial deci sions
of emergency depanment physician s but
wi II help to more efficiently treat patients
whom th ey dec ide to ad mit to the hospita l.
" The rea l impact wi II be two things : One is
that pati ents who don ' t have a hean attac k
will get excl uded and moved out of
intens ive care faster; the oth er area is in
noninvasi ve detecti on of a hean ane!'y
being reopened. Th ere is more enthusinsm
th ere than anywhere else," he says . •

<:""'~
Paul Eisenberg, M.D., director of the Cardiac Care Vnit at Barn es Hospital and
Allan .Jaffe, M.D. , director of cardiac intensive care at Barnes.
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na sense, pain drives
medicine. It's the signal that
something is wrong, that tissue
is being damaged. Pain sends
people to doctors for expert
care. So it is necessary.
But pain is elusive. It can't be
seen or imaged. Despite in
creasing medical precision,
.
.
.
measunng pam remams a
subjective process. Experience
teaches us that cuts and sores
heal; pain will go away. Once it
is gone, it cannot be recalled
accurately.
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Get Help Here
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Sometimes , howeve r. pain grow s to
overwhelm a life. When it won' t moderate
and it won't stop and it begins to color all
perce ption and inter fe re with relationships
and daily li vi ng, th en it becomes more th an
a warni ng and more ihan a sy mptom. Then
it is a disorder all its own th at requires the
attention of spec iali sts li ke th ose at the
W ashington Uni versi ty Pain Management
Center.
As an exa mple, consider the case o f
M ary Jo Rubio. Workin g as a visitin g
nurse in January of 1985. she cared for an
elderl y patient lying in a bed panicularly
c lose to the tl oor. When Rubio strai ght
ened from her tas k, she knew she had hun
her back . Every day since - for more th an
2,700 days now - the pain has bee n with
her. Rubi o says the pain never has been

less th an 4.0 on a I O-point sca le. Like most
chroni c pain sufferers, her pain has
depressed her and laid waste to her plan s.
It has changed her relati onships and
dictated her choices.
When th e intervertebral disk she
ruptured was surgicall y removed 10 days
after th e initi al event, the pain changed, but
it didn ' t go away . In th e tim e between the
initial damage and April 199 1 when Rubio
got to the th en new Pai n M anagement
Center, she v isited 10 dif ferent phys icians
and tri ed everythin g that was offered to her
- from dee p body massage through
relaxa ti on techniques to po werful pain
medicati ons - all with out substantial
effec t. " You ju st grab for anythin g you can
to tind relief," she says. "r worked and
work ed to f ind comfon."

Relief onl y
cam e in any
real measure
wh en her entire
experi ence of
suffering was
anal y zed , th en
treated , usin g
the multid isc i
plinary approach employe d by Robert
Swarm , M .D. , and his coll eagues at the
Pain M anagement Center. Swarm,
coordinator o f th e ce nter and an instructor
in anesthes iology, says Rubio's experience
is unique in detail but not unusual in type .
" Every case is different," Swam) says,
" but when the pain is chronic, the probl em
is always complex ." Chronic pain is
defined as any pain whi ch has continued

Robert A. Swarm, M.D., coordinator 0/ the Pain Management Center, alld BOllnie Henry, R.N. , clinical nurse specialist,
interview and examine patient Marie C. Koenig to assess her pain - the first step in successfully managing it.
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for more than six months. Then, there is
"always an emotional componen t," and th e
need for a broad-spectrum eva lu at ion of
the patient's condition that sets a multidis
cipl inary course f·or treating it.
According to neurobiology, pain begins
when nociceptors (the name given to the
ne rve ce lls dedicated to sensing pain) are
st imulated. They communicate impulses to
the spinal cord and then to the brain, where
suffering starts. Finall y, pain behavior is
displayed, Swarm explains. The perception
of pain equals suffering, he says, and
suggests that perhaps the ce nter he
oversees could be called the "S ufferin g
Management Center," since that's what is
treated there. "We don't treat noc iception;
we try to manage suffering - the whole
experience," he says.
When a patient like Mary Jo Rubio first
comes to the center - having been
refelTed from genera l practitioner to
specialist and then to the center - an earl y
step is to rate the sever ity of the suffering.
Patit'nts are shown a horizonta l line 10
centimeters long and asked to point to the
spot that represen ts the leve l. of perceived
pain. The left end of the line is "0" and no
pain; the right end is "10" and the most
extreme pain imagin ab le. The physician
then measures from the left in centimeters
and reads a numerical value - say 4.2 or
6.7 - for the pain. [n the simplest terms ,
"Our goa l is to move down that line to the
left." Swarm says.
In the etfon to move down the line, the
pain center's collaborators keep foremost
the question : "What is likely to be help
ful?" Called in to consult might be a
psychiatrist to help ease the depression that
so often accompanies chronic pain, a
clinical psychol ogist to refocus attention
away from th e pain , a dietitian to assist
with weight control and dietary choices, a
physical therapist to retrain muscles and
treat movement dysfunction and an
occupational therapist to he lp the patient
with activities of dai ly li vin g. Coordinating
the treatment
and administer
ing medication
and nerve
blocks as
appropriate is
the anesthesi
ologist with
additional
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Mary ,/0 Rubio of Salem, I L, has lived with back pain every day for more than seven
years. Among the physicians she has visited and the therapies she has tried ill
search of relief, ollly the Pain Management Center has proved satisfactory.

specia lty training in pain management.
Pain is so comp lex that it is diffic ult to
describe in genera l te rms. So pain center
personnel emp loy classifications to make
sense of the challenge. At its simpl est. their
model consists of two kinds of pain and
three types of patients.
For the clinician who treats pain as a
di sorder, it can be either nociceptive or
neuropathic. Noc iceptive pain originates
with the ongoi ng stimulation of the nerve
ce ll s dedicated to se nding signal s of
chem ica l, thermal or mechanical damage
to tissue. Neuropathic pain is the result of
damage to nerves. For there to be
neuropathic pain, there need not be
contin uing tissue damage - the nerves
themselves have sustained damage and
continue to send signals of pain after the

acute injury has healed, Swarm exp lains.
"Phys iciun s have been slow (0 recogni ze
such neuropathic pain and to acknowledge
that it is as real as any other," he says.
Patients seen in the puin munugement
center include those with:

ACUTE PAIN - Often post-surgical patients
or victims of trauma, these patients have
had pain for hours , days or weeks.
Frequently , their pain is due to insult to
noc iceptors , thoug h eve n these patients
may have puin of neuropath ic origin.
" Most but not all acute pain patients
respond to opioid medications at conven
tional levels," Swarm says, exp laining that
opioid medications work in the manner of
morphine by blockin g the transmission of
pain signals to the brain. Opioids depress

Ed McCleskey, Ph.D., investigates the
Ileurobiological origills of pain.

Working with nociceptors - nerve
destined for the brain arrives at the
cells dedicated to sensing pain - Edwin
synapse, transmission can be inhibited by
morphine.
W. McCleskey, PhD. , studies pain one
In that regard, morphine mimics the
cell at a time. When we feel pain, he says,
that's not just regular nerve cells being
endogenous opioid system first described
in the ' 70s. McCleskey says that system of
overstimulated. It's nociceptors, nerves
nalllral pain control is remarkably specific:
that don't fire at all until the stimulus
"It affects pain from the main site, but lets
reaches a noxious level.
through other sensa
The job of the
tions." As an example
nociceptor can be
divided into three
or its intricacy. he
parts: I) The painful
points to sllIdies of
soldiers with serious
stimulus is trans
duced at the tip of
war wound~ who,
under the stress of
the nociceptor into a
series of electrical
combat, continued
impulses called
with the ir tasks,
action potentials. 2)
issuing utterances such
The action poten
as, "[ feel it, but [ don ' t
tials travel the
care ," The endogenous
opioid system was
length of the cell's
The sites at which pain medicatiolls
putting down their
axon to the spinal
fllnction vary. (Diagram courtesy of Brain
pain.
cord. 3) The arrival
of the action
Facts, copyright 1990 by the Society for
The endogenous
potentials at the
Neuroscience. All Rights Reserved.)
system is also the
spinal terminal causes the release of a
reason acupuncture works. By creating
small pain, the ac upuncturist's needles
chemical neurotransmitter that activates a
stimulate the release of endogenous
second neuron leading to the brain.
opioids into the central nervous system and
Aspirin subtly inhibits thc tip of thc
nociceptor. Local anesthetics stop trans
bloodstream. And when we rub near a sore
mission along the nociceptor's axon.
spot, we're working to accelerate the
Opiates, by far the most selective and
release of endogenous opioids by addi
tional nerve impulses.
effective pain suppressors, inhibit commu
nicar-ion between nociceptors and the
McCleskey faces several challenges in
his effort to comprehend the roots of pain.
secondary neuron .
Endogenous opioids are among the
Nociceptors don't work in isolation.
Stimulated, they also release signaling
smallest and simplest hormones in the
body, as shOlt as five amino acids.
substances that communicate with the
Morphine, that mimics them so well. is an
immune system. Then the permeability of
blood vessels increases, redness appears,
organic, ringed compound. Why they bind
to the same site remains a question.
and new defenses are called to the fray.
Activated immune system cells exude
Beyond that, no one has yet isolated
histamine and serotonin, sensitizing
nociceptors outside the body, so they are
particularly difficult to study. McCleskey
adjacent ne rves. McCleskey, assistant
is at work on a method that will sidestep
professor of cell biology, says the expand
ing sensiti zat ion is at the root of chronic
the problem of identifying them by
nocice ptive pain , when there's more pain
creating a culture of nerve cells containing
than there is apparent tissue damage.
identified nociceptors.
[n an etlon to understand and control
The work's potential di vidends are
pain, McCleskey strives to fill out the
huge. [f the mechanism by which
nociceptors operate 10 create the experi
biological mechanism by which opioids
ence of pain can be mimicked outside the
work. He has shown that morphine and its
body, it may be possible to screen for
analogs restrict the ability of one nerve to
"talk to" another by inhibiting molecules
drugs that more effectively control pain. A
called calcium channels that control
larger arsenal would be of tremendous
medical benefit.
neurotransmitter release. When a pain
signal originating at the nociceptor and
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the transmis
sion of the pain
signals between
the peripheral
nerves and the
spinal cor(l.
Traditionally,
such analgesics
(pain blockers)
have been administered via injections
every three to four hours.
Swarm and his colleagues use such
Injections but also employ more powerful
techniques including the epidural applica
tion of local anesthetics or opioid analge
sics. An epidural is so-called because pain
medication is delivered outside or above
("epl") the "dura" (the outermost layer of
tissue surrouncling the splllal cord) They
also sometimes use local anesthetics to
block the nerves that transmit pain signals,
and they may control the nociceptors at the
site of the tissue damage by delivering
anesthetics to the inlured skin and muscle.
In some cases, patients are given control of
their own pain management via patient
controlled analgesia (PCA) devices that
use a ponable pump to deliver carefully
measured pain-quelling doses of medica
tion.
The relief of acute pain is clearly
humanitarian, Swarm says, but equally
imponant is the opportunity it provides.
Patients free of pain turn, cough and
breathe deeply sooner after surgery than
those who suffer intensely. They also can
become involved in their physical therapy
more quickly, and evidence is growing that
they heal faster. Complications and
possible side effects are possible with
strong pain therapy, but they must be
weighed against the risks of untreated pain,
such as pneumonia, the effects of immobil
ity and perhaps chronic, severe pain,
Swarm says.
Pain center personnel also push the
~'rontiers of pain therapy by treating pre
surgery patients - dulling nociceptors at
the site of the future incision on the basis
of increasing evidence that sLich early
intervention potently reduces post-surgical
palil.

damage. Others are diabetics with the
complication of peripheral neuropathy 
pathological changes in the nervous
system. But 50 percent of such patients
suffer back pain. Most of it, Swarm says, is
the result of a work-related injury or
acquired through degenerative anhritis of
the back, as in Mary Jo Rubio's case.
The original source of the pain is
sometimes replaced with reflex sympa
thetic dystrophy (RSD) - a relatively
common but poorly understood
neuropathic condition that centers an
exquisitely painful region on the site of
earlier trauma and sometimes evolves into
cold, swollen extremities that subsequently
become useless.
In many such cases, a physical therapist
consults in the treatment. Jay Diaillond,
M.H.S./P.T., a pain-center collaborator
from the Irene Walter Johnson Rehabilita

tion Institute, says he takes a four-step
approach to physical therapy for chronic
pain sufferers. First, he learns from
patients what body area hurts, when it
hurts and what diminishes the discomfort.
"I try not to dwell on their pain but on their
decrease in functional activity as well as
what they want to do that they presently
cannot do," he says. Then he performs an
exam, ob~erving both the quantity and
quality of Illovement. He identifies
postural and structural misalignments and
muscle lengths and strengths that contrib
ute to a diagnosis for the particular
movement dysfunction. Finally, an
exercise program is devised to restore
proper mobility.
"If a patient says his back is killing him
every time he stands up, then I watch him
stand," Diamond says. The goal: to get him
to move correctly, using proper body

CHRONIC NON-CANaR PAIN -

Some
patients with chronic non-cancer pain
suffer from vascular disease and ischeillia
of the lower extremities that leads to nerve

Clinical psychologist Stephen Ristvedt, Ph.D., of the Behavioral Medicine Center at
Jewish Hospital, contributes to the team approach to pain management by assisting
patients with the emotional component that accompanies chronic pain.
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Employing relaxation techniqu es he
eases tension. Biofeedback helps pati ents
ga in local control over their mu scles. An d
Ristvedt intervenes in some of the soc ial
aspects of pain behavior to address the
fri ction that sometimes deve lops when the
co ntribution by the patient is restricted.

CHRONIC CANCER PAIN - Swarm says that

"The philosophy of 'no pail!, no gain, ' does not hold," says physical therapist Jay
Diamond, M.H.S.lP.T., of the Johnson Rehabilitation Institute. Diamond trains
patients to move correctly, using proper body mechanics to reduce their pain.

mechani cs and muscle recruitment so it
does not result in pain . "The philosophy of
'no pain, no gain ' does not hold," he says.
Diamond also esc he ws quick fi xes and
what he ca ll s "p hysical agents," like hot
packs and ultraso und. "The pati ent must be
involved and responsibl e for hi s own
therapy. Many are deconditioned. Relief
won't come overnight, so the imponance
of patient control over rehabilitation is
reinforced," he says.
Another frequent contributor to the
team approach to pain management is
Stephen Ri stvedl. Ph.D., a clinical
psyc hologist with Jew ish Hospi ta l's
Beha vioral Medicine Center. Ri stvedt says
hi s patients often ex perience a se nse of loss
at what they belie ve is no longer possible
for them. He intervenes to assist them with
their depression via cogn iti ve therapy.

Helping them requires breaking the loop
between how they think about their futures
and their pain-restricted behavior. It may
require log ical arg ument and it may require
encouragin g them to test their limitations,
Ristvedt says.
He al so helps patients cope with their
pain by directin g their atte ntional mecha
nism s away fro m the pain. A common
exerci se is to as k the pati ent first to
concentrate fuJly on hi s or her pain for a
matter of minutes. Then the patient is
asked to focus e ntirely on something else
- a book, a sight , a favo rite hobby - for
the same length of tim e. The di straction,
Ristvedt says, can be instructive ; many
patients can use distracti on tec hniques to
learn to differenti ate betwee n what he calls
"OK pain," or tolerab.le pain , and "not OK
pain."

60 percent of cancer patients will suffer
moderate to severe pain with their di sease
or it s treatment at some time. At best, he
adds, only 50 percent of those will have
th eir pain adequately relieved, even in
developed countries.
Th at's more the fault of uninformed
physicians than it is a problem of resistant
pain . Swarm says: "The appropriate use of
oral opioid medications will control pain
for well over 90 percent of cancer pain
patie nts. Of course, you can't just give
these patients morphine and send them off;
you must anticipate and treat the side
effects and repeatedly adjust the dosage.
Access to analgesics is very important for
cancer patients. " For the five to 10 percent
whose cancer pain persists, Swarm may
empl oy nerve blocks or more potent routes
of ana lges ic administration.
Bonnie Henry, R.N., clinical nurse
spec ialist in the Pain Management Center
ex pl ai ns th e team 's overall approach: "We
don ' t just presClibe pain medication. We
search for the SOllrce of the pain through a
broad, multidi sc iplinary evaluation. If we
can't eliminate the cause, then we de vise a
management plan , provide the necessary
support and give psychological help in
coping with it. Even though all the pain
may not be gone, we can bring back a level
of functi oning these patients thought
they'd never have again."
Does that approac h work') Listen to
Mary Jo Ru bio com ment as she slides a
cake into the ove n: ,. They've been the
only people who ever helped me. I do
whatever they tell me. I ca n get prell y sad
thinking about the future. but they help
with the pain
and they help
me avoid that
depress ion." •
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A rare photo of
Barry Wood, M .D .•
shows IIilll at his
de k. The il/scrip
tioTl: "To Kell Killg,
Illy last clillical
teacller. " is a
referel/fe 10 Killg's
lime as chief resi
deut, durillg which
he reported daily to
Wood 011 all admis
sioTls.

BY M. KENTON KING,
20
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EACHER,
reci se ly 50 years ago, William BaITy
Wood, Jr. , came to Washini;lOn Uni ver
;, ity a;, Busch Professor and Head of the
Depal1ment of Internal Medicine, He had
been recruited by Philip ShafTer, with
assistance from Evan;, Graham, He was
destined to stay for I] years and to achieve
great prominence in academic medicine.
BaITY Wood was born May 4, 1910, in
Milton , iVlassachusetts. Hi, father was a
Harvard graduate and a cotton broker.
Barry attended M ilton Ac.ldemy , where his
talents a;, a sLa r athlete in several SpOI1 s. a
brilliant student and a natural leader first
became evide nt. 1t was a foregone
conclusion th at he wou ld attend Harvard
( 1928-1(12). and his record there wa;,
unbelievabl e. He earned nine v,w,ity letters
as a quarterback, Center on the hockey
team, star short stop and first baseman and
captain of' the football team, He was a

R

un,lnimous choice as All-American
quarterback. He earned a tenth letter In
tennis . He grad uated \"1/11111/(/ CI/III /(/ucie
and was first marshall of th e senio r class.
During hi s student days at Harvard ,
BaITY work ed with L.J. l lende rson in the
f~ltigue laboratory, studying the e ffech of
.'itn.:n uous exe rcise on the leukocyte co unt.
He found that the count t'requently doubled
in shol1-distance runners, but quickly
returned to normal. In football playe rs,
with more sustained exertion. the count
mi gh t increase by ,I factor of three or four
an d re main elevated for hours. With this
work began a lifel o n ~ sc ientific interest in
the role of the leuk ocyte,
When Barry was a boy , hi s famil y spe nt
a part or each summer In Maine at a ca mp
shared with three other families . It was
there that he met :vIary Lee Hutchins, or
L.eal. She wa.~ at Vass,lr while he was at

Harvard , and soon after graduation , the
two married. During his se ni or year, Barry
had written a book titl ed Whol Price
FooliJo/l. The roya lties from the book.
written by an AII-Americun quarte rback,
helped fin~lIlce the first few years of
marriage.
After graduation from coll egt:' . Barry
decided to go to medical sc hool at Johns
Hopkins de~pit c strong con trary advice
from a number or "B o ~lo n Brahmin
Ph ys i c ian ~ . " lie felt that it wou ld he good
to get away from Boston, where he had
spent nearl y all of hi s life. Leal\ father was
a physician who had trained at Johns
Hopkins, and he had often spoken of what
a wondeli'ul place it was. BJITY and Lt:'al
lived ncar thc Hopkins Hosp ital. Leal went
to Goucher and then lO The Hop kins
School of Publi c He alth whil e Barry was a
med ical stude nt Both ofte n spoke of these
as among their happiest days.
Tn medical ~c h()ol , Barry worked in the
laboratory of' W . M'ill ... tield C/,u'k .
in vestigating oxidat ion-reduct ion poten
tials. One summer he took a clerkshi p at
The Boston City H(bpital. where he was
exposed to ~li m ulal ing clinical te achers:
Soma We is .... \V illiam Castle and Chester
KL'efer. Although telllpted to go into
biochemistry upon graduation, he decided
instead to pursue c lin ica l med icine and
we nt on to internship and ass istant res ident
appointments at Hopkins, on the medical
service headed hy Warfi eld Longcope.
While still a resident phySician, Barry,
encouraged by I,ongcope, visited Oswald
T. Avery at th e Rnekefe ll er Institute in
ew York. lie was fa ... cinated by Avery's
account of th e who le story of the pneumo
coccu.\ capsule and the polysaccharide ....
Upon compl eti on of his residency, he
returned to Boston as a fellow in the
bacteri ology depaI1l11ent of H a n ~ Zin sser.
Zinsser wa ... chro ni ca ll y ill , so Barry was
a... signed to work with John Enders, Wood
and Enders developed a laboratory model
of pneumococca l pneumonia in rats, based
on eal'lier work by Nungester. Thus. Wood
wa~ launched upon studying the role
leukocytes play in recovery from pneumo
coccal pneumonia.
Wooel returned to John,> Hopkin s for
two years ( 1940-42) with the title of
assistant in the depanment of medicine. In
1942, at the age of .12 and only six years
aft er receiving hi ... VI .D deg ree, he
,lcee pted th e position of professor and head
21

Harvard

WILLIAM BARRY WOOD

Vice-president , J ohnll Hopkins Univerdiltl & HOll/l itul
and after each game in his last season at
Harvard. Captain Barry Wood jabbed his
thumb and t he thumbs of agreeable team mates,
collected the blood smears on slides. Captain Wood,
Quarterback, was curious a bout the effect of mus
cular exertion on t he leucocytes (white corpuscles) .
Harva rd has never forgot ten Barry Wood ; the Crim
son has not had an All-America backfiel d man since.
And Wood has never forgotten the leucocytes; his work in microbiology has
led medicine well beyond old frontiers of knowledge about the role of the
white blood cells in fi ght ing disease. Today, as vice-president of the Johns
Hopkins University and t he Johns H opkins Hospital , he is the direct i n~ offi cer
of a major sh are of America's medical research. He was the only una nimous
choice of the Silver Anniversary judges.

B

EFORE

In 1956, Sports Illustrated selected the 25 footballlellermen of 25 years earlier "who have most distinguished them selves in
their chosen fields of life." The only unanimous choice as one of the "Silver All-Americans" was Barry Wood. (Re printed courtesy
oJ Sports Illu stratedfrom the December 24, 1956 issue. Copyright 1956. Time, Inc. A ll Rights Reserved.)

.I
of the Department of Medicine at Wash
ington University. He was, in his own
words, "t1abbergasted" at the offer. He was
only three years beyond house-officer
training, and the heavy profess ional
responsibilities would make it difficult to
do research. Hi s mentors at Hopkins
adv ised against taking the position, but the
attraction of the offer. and especiaJJy the
challenge, were too great to resist.
Washington University, too, had
gambled tremendously, handing one of the
most important positions in its medical
school to a young man whose bibliography
contained fewer thaI) 10 papers (four more
were published after the appointment had
been anno unced). The gamble, however,
paid off handsomely , perhaps beyond the
dreams of those who engineered it, as
Wood later became a leading figure in
academic medicine in this country.
In St. Louis, Wood was wise enough to
hang back just a bit while learnin g the
ropes from Harry Alexander, Alfred
Goldman and Sam Grant. These experi
enced clinicians guided him and quieted
those who worried about the green young
man. Wood also adhered strictl y to the
admonition of his wife, Leal. never to
menti on Johns Hopkin ~. But Barry learned
22

fast, w, all who came to know him in St.
Loui s realized. He built a fine department,
attracting an exce llent young facu lty
including William Daughaclay and a steady
flow of superior house officers including
early chief residents Edward Reinhard ,
Llewellyn Sale, Jr., Robert J. Glaser,
Ernest Rouse and Bernard Galfinkel.
Wood became an exceptiona l clinician, a
tremendous ly stimulating teacher at the
bedside and a leader among the senior
faculty.
Why was Barry Wood a great man') He
was highly intelligent and we ll -educated,
but so are many others. He worked very
hard. He had a capti vating personality and
was well-liked by almost everyone, but
suc h trait s are not rare. These qual ities
on ly formed the fou ndation of his make
up.
Those who knew BUiry Wood well
agree that he was different from anyone
else they had ever known. He was born to
lead. He had a special knack for making
every patient, every case, seem fascinating.
Boredom was unknown to him . His
enth usiasm for quality was highly infec 
tious. He increased the se lf-esteem of those
around him by expressing confidence that
they would perform well, and so they

usuall y made a special effort to do so. He
applauded their successes generously. He
spoke to all persons with remarkably equal
attention and respect , especially st ude nts
and young people: deans and presidents
received equal , but not extra, attention. If
Barry was talking to a student in a crowded
room, and a stream of dignitaries filed by ,
hi s eye contact and hi s <Jttent ion remai ned
totally with the you ng person until the
con versati on ended. This quality greatly
impressed scores of young peop le.
Barry ne ver, ever initiated comment
about hi s athletic career. Others frequently
brought it up, mentioning this or that great
feat on the grid iron against Army or Yale.
He would smile, pull at his ear lobe, and
offer a comment such as. "That was a long
time ago."
During 13 years in SI. Louis, Wood
published 47 scienti fic papers, including
21 in the Journal of E~pe,.imenlal Medi·
cine, two in the Journal of Immunology,
and two in Sciel/ce. He managed to make
time for research despite a great many
competi ng activit ies. He continued to work
on the mechanism of recovery from
pneulllonia, including the importance of
surface ph<Jgocytosis and became inter
ested in the pathogenesis of fever. He was

elected to the National Academy of
Sciences in 1959.
Barry served as President of the Central
Society for CI inical Research, the Ameri
can Society for Clinical Investigation and
the Association of American Physicians.
He also served on the Board of Overseers
of Harvard College, the Armed Forces
Epidemiologic Board, the Board of
Trustees of the Rockefeller Foundation,
and the President's Science Advisory
Committee.
He declined to be considered for
chancellor of Washington University but in
1953 was listed in newspaper accounts as
one of three finalists for the position of
president of Harvard University. Nathan
Pusey was chosen. Wood later responded
to an urgent call from his medical alma
mater and accepted the vice presidency at
Johns Hopkins in 1955.
BaiTY and Leal had five children 
Bill. Margo, Peter, Jonathan and Jean 
and enjoyed them immensely: The
Woods' St. Louis home, off Litzinger
Road, was the scene of many happy
activities. The "swimming pool," which
seemed to be only 12 feet wide and 15 feet
long, was the family's focal point in the
warm months. In the later home in the
Green Spring Valley, north of Baltimore,
members of the family came and went at
their various activities. Barry did not
isolate himself from the family in order to
work during the evening. He often sat in
the middle of the living room, surrounded
by family, as he worked on a paper for
publication. Those who watched television
were required to wear earphones.
A. McGehee Harvey of Johns Hopkins
said of Barry: "That he was a rare human
being was clear to all who knew him ....
Barry aimed constantly for excellence in
everything ... in research, in teaching, in
administration and in SpOi1s .... He was a
great teacher, for whom teaching was a
sacred trust ... giving everything his best,
he inspired others to do their best; and so
he led by example, softly."
From Walsh McDermott of Cornell
comes this comment: "Barry had a truly
extraordinary ability to bring himself into
the lives of others and make them better
for it ... those whose lives were touched by
Barry came to know not necessarily the
world's greatest scientist ... but a truly great
man

Milton Eisenhower, then president of
Johns Hopkins University, put his finger
directly on the point, saying: "He was wise
because his spirit was uncontaminated,
because he knew no violence, or hatred, or
envy, or jealously, or ill will. I believe that
it was this purity that chieny made him the
(man) we so much revere ... it was a rare
good fortune that brought to such emi
nence a man so reserved, so unassuming,
so retiring, so gracious to high and low.
and so serene."
And from Barry's housekeeper, Rosa
Capers, who joined him after Leal's death:
"Doctor Wood always made me feel so
important." In one line she expressed what
so many had felt.
Robert J. Glaser, M.D., a long-time
friend and colleague of Barry's, who
served as dean of two U.S. medical schools
(Colorado and Stanford), as director of two
major medical foundations (Henry 1.
Kaiser Family Foundation and The Lucille
P. Markey Charitable Trust) and is a
Washington University trustee, inter
viewed Barry on tape shortly before his
death.*
Summarizing Wood's position in
American medicine, Glaser says: "In his
era Barry Wood was one of the most
respected individuals in American
academic medicine. Those who knew him

at Washington University regarded him as
a superb clinician, a stimulating teacher,
and a productive investigator. Nationally,
he was widely respected as a wise counci 1
lor and role model. His tragic death took
from the scene a man who, in my opinion,
was a giant in the best sense of the word."
Barry Wood died suddenly on March 9,
1971, in Boston, where his career had
begun. He was there to attend a dinner
honoring the retirement of Nathan Pusey,
president of Harvard University.
"This tape is in the medical library in the
"Leaders in American Medicine" series. sponsored
by Alpha Omega Alpin Also available lrom [he
AOA office, 52') Middlefield Road. Suite UO.
Menlo Park, CA 94025.
Ackllol\'!fdg('IIIClilS: The author gratefully

acknowledges three sourccs: IjPresclltatioll of the
Kober Medal tor 1971
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W Barry Wood, Jr., by

Carl V Moore, M.D. 2) Willialll Barry Wood, Jr,
by James G. Hirsch. M.D. Biographical Memoirs,
National Academy of Sciences, Vol. ') I. 19f(O, and
(1) Memorial Service, The Johns Hopkins Medical
Journal. Vol. 129, August, 1971
EdilOr'.1 Norc: Tile author worked daily with

Barry Wood tor six years. in both 51. Louis and
Baltimore. He and Mrs. King (June) lived in [he
Wood family home, north of BaiIill1ore. for portions
ofrhree .summers, while the Woou lamily was
vacationing in Maine . •

Wood is shown with students on the ward ill what was called a "student laboratory."
In the bow tie is Robert ./. Glaser, M.D.
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The larges t Sc hoo l of
Medici ne c lass in seven
yea rs - 130 stu de nts 
gradu ated ea rl ie r th is yea r
afte r rak in g pa rt in the
Nati o nal Res ide nt Matc hIn g
Prog ra m. More than three
quarters of the graduatin g
stu de nt s, full y 76 perc e nt ,
will be do in g th eir post
gradu ate trainin g at one of
the ir top three choices o f
insti tuti ons. And 56 pe rcent
will tra in at their firs t c ho ice.
Int e rn a l med ic ine re
mained the mos t freque nt
c ho ice a mong reside nc ies,
se lec ted by 43 of the Sc hool
o f Medic ine grad uates. That
fi gure re prese nts a perce nt
age equi va le nt to th e
prev ious cl ass, whe n :13
percent also opted for
res id e ncies in medici ne.
Ch oices re fl ec tin g increased
po pul ari ty thi s yea r were
surge ry and res ide ncy
programs desc ribed as
"tran siti onal" be fo re spec ial
ti es suc h as anes thes ia.
Pedi a trics a nd radi o logy al so
re mained popul ar choices.
Fi fty-seve n o f th e new
ph ys ic ian s will stay in
Mi ssouri for th eir post
gradu ate trainin g, 48 of th em
at Was hington Uni ve rsit y or
affili ated in stituti ons. Othe r
co mmon des tinations:
Califo rni a (1 3 stude nt s),
Illinois (to) , Massac hu se lls
(9) anci Texas (9). Th e
co mpl ete li st fo ll ows. Some
names may be li sted more
th an once beca use of
pre liminary and trans iti onal
res ide ncies.
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ALABAMA
B irming lwl/1
Universi ty o f AL Hosp ita l
General Surgery
Terrill, Stephen G.

501/ Diego
U.S. Naval Hospital
Tra nsitional
Kon ebei n, Patrick M.
Miller, Jeffrey S.

ARIZONA
Phoenix
Good Samari ta n Hos pit al
Ge ne ral Surgery
Kunes, Marga ret L.

S/({I!fiJrd
Swnford Affili ated Hospital
Ge nera l Su rge ry
Morris, Jonat han A.

Sr. Josep h's Hosp.lMed. Or.
Internal Medi c In e
Beck, Brenda C.

CALIFORNIA
Fresno
UCSF/Fres no Vall ey
T ra nsitio nal
Stei n, Steve n J.
Angeles
UCLA Med . Or.
Pa tho logy
S hi buya, Robe rt B.

L O.I

Radi o logy - Di ag nos tic
Heiss , Steve n G .
Sacra mento
Uni v. of CA -Dav is Med . O r.
Medi c ine-Pr imary
Redm ond , Gregory S.
Obstetri cs -Gynecology
Lee, Jo n G .
Son Fro ncisco
CA Pac ifi c Med. Or.
Intern al Medi cine
Cortl and , Da wn D.
Medi cine - Prelimina ry
Baranski , Karen J.
Ophthalmo logy
Shin , John C.
Uni ve rsit y o f Californi a
Intern al Medi cine
Baran ski , Th omas J.
Radi ology - Di ag nos ti c
.Bl.l1an sk i, Kare n J.

COLORADO
Del/ ve r
Unive rsity of Co lorado
Anesthesio logy
Ste in, Steven 1.
CONNECTICUT
FOl'/nin g/ol1
Uni vers ity of Conn ec ti cut
Surgery - Pre li minary
Pu stil nik . Stephe n M.
New HCIl 'en

Yale-N ew Haven Hospital
Anes thes io logy
Rh im, Sunghee
Medi cine -Pri mary
Rhim , Sun ghee
Ob stetri cs -G y neco logy
Pu stilnik , Terri B.
Pedi atri cs
Pappano, Da nte A.

FLORIDA
Tompa
Uni ve rsit y o f South Flori da
Ped ia trics
Da vis, Grace V.
GEORGIA
A/Ionia
Emo ry Uni versity
Obstetri cs-G yneco logy
S pec tor, Mi c he ll e
Tra nsitional
Blatt , Andrew N.

HAWAII
HOl/olul1l
Tr ip ier Army Med. Or.
Pathology
Fra nk, David R.
Trans it io nal
Frank, Dav id R.

IOWA
Des Muin es
V A Med ica l Cente r
Surge ry - Pre lim inary
G hour i, Ahmed F.
ILLINOIS
Chicago
Coo k Cou nty Hosp ita l
Emerge ncy Med ici ne
McCrae, Paul a C.
Loyo la Medical Ce nter
Ge n. Surge ry - Prelim .
Stok es, I] L Sa m
McGaw Medi ca l Ce nte r
In ternal Medici ne
Stosor, Valentina
Vi nci, Li sa M.
Ru sh -Pres . SI. Lu kes Med.
Ct r.
An es th es iol ogy
Sample, Madi so n
Pediatrics
Patters on, Lee V.
Uni vers it y of C hicago
Hosp ital s
Pedi atri cs
Suggs . Adrie nn e H.
Waggon e r, Dar rel J.
Radiology - Di ag nos ti c
Funaki. Bria n S.
EV O/1s /ol1

Eva nston Hospit al
Tran s itional
Shin , John C.

LOUISIANA
New Orleans
Tul a ne Uni v. Schoo l of
Medi cine
Ge ne ral Surge ry
Thomas, Jr. , Th omas V.

MARYLAND
Bo/,il/wre
Uni ve rs it y of MD Med .
Center
Radiology -Di ag nostic
S heafo r, Dou gla s H.
MASSACHUSETTS
Boslon
Mass. General Hospital
Ane st hes iol og y
Baker, Ke ith H.
Prakah-Asante, K wasi
Woon, Anni e P.
Ge nera l S urge ry
Lin ge lbac h, Jane M.
Interna l Med icine
Ha y, C hri stin e M.
Brigham & Women 's
Hosp ital
Anesth esiology
Rothman, Mark C.
New England Deaconess
Hosp.
Internal Medici ne
Leibo witz, Matthew R.
CwniJriciKI:'

Cambridge Hosp it a l
Tran s iti o nal
Woon, Annie P.
Mount Auburn Hospita l
Med icine-Pre Iimin ary
Spraul, Jos eph W.

MICHIGAN
Alll1ArDOr

University of MI Hospita ls
Internal Medicine
Sasseen, Bre tt M.
Pediatri cs
Gomez, Carly A.

MISSOURI
Co/wl1iJia

Univ. Hospital & Clini cs
Family Practic e
Stevermer, Jam es J.

51. LOllis
Barnes Hospital
Anesthesiology
Jones, Stephani e B.
General Surgery
A ft- Keni gs berg, Rebecca
Ge nera l Surgery - Pre lim .
Griffiths , Ru sse ll H.

Peter Fishbach (at right) congratulates a trio offri ends on their residency appointments during
Match Day, From left, the three are Carlos Arcal/geli, David Ritter alld Patrick Kortebeill.

Internal Medicin e
Bernstein, Marc J.
Hazen, Stanl ey L.
Horning, Neil R.
Kaufman, Ri chard M .
Kennedy , Charlotte J.
Leimba c h, Mark E.
Reikes, Sanford T.
Westervelt, Pe te r
Laboratory Medi c in e
Watso n, Mark A.
Medicine - Preliminary
Hillier, David A.
Orthopedic Surgery
Brown, Christoph er A.
Liakos, Photine
Sol a. James B.

Radiology - Diagn os tic
Malden, Eric S.
Semin, Michele D.
Surge I'y-Pre lim inary
Arcange li, Carlos G .
Cho, Judith E.
Ojemann, Jeffrey G.
Soares, Robert L.
Jewis h Hosp ital
Interna l Medicin e
Brown, Angela L.
Novoa, LoUIs J.
Int. Medicine - Prelim .
Prakah-Asante, Kwasi

Plastic Surgery
Gr iffith s, Ru sse ll H.

Medic ine - heliminary
Baker, Keith H.
Carnes, Kenn et h M.
Gorman, Dou g la s S.
Hultsc h, Anne-Lise A.
Jones, Stephanie B.
Lai , Ja mes Z.

Psychiatry
Harvey, Steven A.

Rad iology-Diagnoslic
Ze la7.ny, Anlhony M.

Pathology
In ge ls, Stephen C.

St. Johns Mercy Med. Center
Transitional
Garcia-Ferrel', Fran cisco
H eis~. Steven G.
Martin, Da vid P.
Rothman, Mark C.
Family Practi ce
Hoeb.e ma, Gr:tnt S.
Newe ll. Astrid F.
St. Lou is Childrens Hospital
Pediatrics
Altura, Rachel A.
Bac harier, Leonard B.
Hershey, Andrew D.
Hershey Khurana , GUfJit
McGuire, Mary C.
Thio, Kwee Liu Lin
St. {Vlary' s Hea lth Center
Med ic ine- Prel iIII in ary
Samp le, Madi son
St. Louis University
Pediatrics
Mc Haney, Mark B.

2S

Washington University
Neurology
Carnes, Kenneth M.
Gorman , Douglas S.
:'\i curos urgery
Ojemann, Jeffrey G.
Ophthalmology
Blatt, Andrew N.
Garcia-Ferrer, Francisco
Otolaryngology
Cho, Judith E.
Urology
Arcangeli. Carl os G.
MINNESOTA
Minn eapolis
Hennepin County Med . Ctr.
General Surgery
Colben, Mary E.

Univ. of MN Hosp. & Clinic
Interna l Med icine
Ca naday, David II.
Holman, Russell L.
Manclal. Robert W.
Noe/lester
Mayo Graduate School
Anesthesiology
Martin, David P

NEW HAM PSHIRE
Lebanon
Danmouth-Hit chcoc k Med .
Ctr.
Radiology- Diagnostic
Reinhart , Robert D.
NEWJERSEY
Nell'({rk
l lMDNJ - NJ Medical
School
General Surgery
Brenner. Bruce M.
NORTH CAROLINA
Chapel Hill
University of NC Hospitals
General Surgery
S/.werc, Michael F.
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Dllrhall/
Duke Univ. Medical Cen ter
Internal Medicine
Desai, Sanjay A.
Quackenbu sh, Robert C.

NEBRASKA
Li nc(}ln
Lincoln Med. Education
Foundation
Fa mily Practice
T reptow, Craig L.
NEW YORK
New York
Ml. Sinai Hospita l
Interna l Medic ine
Schwartz, Jon atha n

Surgery - Preliminary
Lederman, Eric D,

NY University Med. Ct r.
Interna l Medicine
Fedor, Matthew C.
Presbyterian Hospital
Interna l Medicine
Chapman, Jeff T.
Pediatrics
Moon, Anne M.
St. Lukes-Rooseve lt Hospital
General Surgery
Orn stein, David K.
Nochester
Strong Memorial Hosp
[ntern a I Med ici ne
Bennett. Norman E.

OHIO
Cin cinll(/fi
Univ. of Cincinnati Hospital
Pediatrics
Finn , Gregory K.
Rankin , Denise M.
Zupan , Andrew A.
Clelle/onci
Mt. Sinai Med ical Cente r
Em ergency Medicine
Eitel , Janice R.

ColulI1bus
Ohio State University
Ophthalm o logy
Spraul, Joseph W.

OREGON
Portlond
OR Health Science Univer
sit y
General Surgery
Lum, Sharon Shou Jen
PENNSYLVANIA
Bethlehell1
Sl. Lukes Hosp ital
Tran sitional
Reinhart, Robert D.
Philadelphia
Chestnut Hill Hospi tal
Tran sitional
Antell , Andrew G.

Hospital of the Univ. of PA
In ternal Medicin e
Donahue, John K.
Templ e University Hospital
Medic in e - Preliminary
McCrae , Paul a C.
Uni versi ty o f Pen nsy lva ni a
Radi ati on Oncol ogy
AntelL Andrew G.
Pillsl)Urgh
University Health Center
Internal Medicine
Gudeman , Su sa n J.

Med ic ine - Pre limin ary
Ch en, Diana M.
Obste trics-Gyneco logy
Bl om quist , Joa n L.
TENNESSEE
Memphis
Un iversity of Ten nessee
Medicin e - Preliminary
Johnson, Byron, W.
TEXAS
Dol/os
Baylor Univ. Medica l Cen ter
General Surgery
Kwa , Julie A.
Ritter, David W.

Uni v. of Te xas -SW Med.
School
Ane sthesio logy
Ghouri, Ahm ed F.
Ophthalmology
Lai, James Z.
5([/1 Antonio
University ofTX Health
Science Ctr.
Obstetrics-Gynecology
Pfanstiel , Ingrid R.

Wilford Hal l t:S .\F Med.
Ctr.
General Surgery
Ii1l1at, Danie l M.
Ka semsap , Pachav it
Psyc hiatry
Skop, Brian P
Temple
Texas A&M - SCOl! & White
Anesthesiology
Thompson, Paul A.

VIRGINIA
Charlottesville
University of Virginia
Orthopedic Surgery
Haka la, Brian E.

Pathology
Ko lar, Brian J.
WASHINGTON
Sea ttle
Virginia Mason Hosp ital
General Surgery
Bradshaw , Barton G.
CANADA
Montreol
Montrea l Gen. Hosp. McGill Univ.
Radiation Onco logy
Coke, Courtney C.
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The '92 Reun ion Alumni A ward recipients (left 10 right): Harry S. lonas, M. D. '52, (Alumni Achieyement Award); Brent M.
Parker. M.D. '52, (Alumni A(:ilievemellt A ward); Bernard Becker, M.D., (Distinguished Service A ward); 101111 D. Dayidson,
M.D. '52, (A lumlli/Facuity A ward); Frederick D. Petersoll, M.D. '57, (Alumni/Faculty A ward); Willialll M. Landau, M.D. '47,
(Alumni/Facu/ty A ward) alld Robert D. Ufiger, M.D. '57, (Alulllni Achieyemelll Award).

Alunml
Achievenlent
Awards
Harry S. Jonas, M.D. '52.
is the director of the divi s ion
of undergraduale meuicai
education and . e cretary of
the Liai son C ommittee on
Me dical Educat ion (LCME )
of the American Med ica l
Association. Prior to
accepting that position in
1987, he wa s associated with
the School of Med ici ne at
the Univers ity of M issouri in
Kan sas C ity for 21 years, the
last nine as dean .
Under Jo nas' le adership.
that medical school ac hi e ved
the respected sta lU s it enjoy s.
His dedication lo qualit y
medical educatio n t )o k him
to the position of nati onal
influence he now h() lds . in
recent years he ha\ b 'e n ~i t c
visit secre Ulry for the LC E
to major mcli ica l schools and
has provided COIL u ltat io n to
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a number of educational
institutions.
lJis student !'. remem he r
Jona s as a "very special
dea n" who knew each of
them perso nall y and was
alwa ys accessible. T hey
search for superla tives with
which to express the ir
adm iration fo r him , callin g
him "an incredible teache r"
and " an extraordinary
clinician." C oll eag ues
describe him as one who
" has used his re mar kable
energy and abilities to ma ke
significant contributi o ns to
hi s profL"; ~ ion and his
community and ye t has time
for family and a host of
friends. ,.

clinical affairs at the Univer
sity Hos piwls ano clinic s.
Parker spent 14 years at
Was hingto n Univers ity as
ass is tant and assoc iate
professor of medicine, co
director of the cardiology
divi s ion and director of the
Adul t Cardiac Cathete riza
tion La bo ratory. From 1957
to 1959 he served as section
chief of cardiology at the
Ve terans Ad mini stration
Hospital, nivers ityof
Oregon .
Amo ng the honors he has
recei ved are the rthur E.
Strau ss A wanl from the St.
Loui s Heart Association and
the Preven tive Cardiology
Acade m ic A wa rd from the
Nationa l Heart Lu ng B lood

Brent M. Parker, M.D. '52,

In ~ l i tut e .

is profes: or e m ' ritus of
medicine at tht· n iv er~i t y of
Mi ~~ o uri a t Colum bi a, where
he teache s part- lime . Fo r s ix
years he was chie f o f' ~ taff
and assoc iate dea n for

He h a ~ bee n repeateJ ly
reco g ni zed for hi . s uperb
teach in g. rece ivin g the
O utsta nd ing Tea che r Award
at the Uni versi ty of Mis oun
in 1974. the Goltle n Apple

Award in 1975, and the
Teacher o f the Year in
C ard iova scular Disease
A ward from the A merican
He arl Asso ·iation. C ouncil
on Cli nical C ardiology in
1986 . He is more than an
ad mired and res pected
professor ; he is a tre asured
friend whose contacts with
hi s students endure lo ng
a ftcr graduation.

Robert D. Utiger, M.D. '57,
is cli nica l pro fessor of
medici ne at Ha rva rd Medical
School and deputy editor of
the " e w E ng la nd Journal of
Med icine ." Fro m 1979-89 he
served a s di rec tor of the
cli nical res arch u nit a t the
U nive rsity of o rt h C aro lina
Sc hool of Medi c ine , wh ere
he wa~ Verne S . Ca viness
Pro fessor of Investigat ive
Medicine . Before g oi ng to
NOl1h Curol ina, Uti ger wus
pro fes sor of medic in at th
University of Pennsylva nia

r
School of Medicine, where
hc was chief of the endocrine
section of the department of
medicine .
Utiger becaine interested
in research while in medical
school and subsequently has
made major contributions to
the field of endocrinology.
His research has focused on
the interrelationships
between the pituitary and
thyroid glands, and he
pioneered in the develop
ment and application of
assays for thyroid-stimulat
ing hormone and other
hormones of the pituitary
thyroid system . Through his
exemplary editorial work,
Utiger is a national influence
for the highest standards in
the publication of informa
tion for the medical profes
sion .
His peers describe him as
a "very fine clinician:' "a
modest person with a
delightful sense of humor,"
and a "thoroughly dedicated
researcher and teacher."

AlumnilFaculty
Awards
John D. Davidson, M.D.
'52, is associate professor of
clinical medicine at the
School of Medicine and
director of the division of
hyperbaric medicine at SI.
Luke 's Hospital. He com
bines these responsibilities
with a busy private practice.
He is particularly inter
ested in hyperbaric oxygen
therapy and in the effect of
hyperbaric oxygen and
growth factors on hea ling in
isc hemic wounds. He has
been influential in the
resurgence of interest in thi s
therapy , which has the
potential for signi ficantly
reducing healing time.
He has been active in the
alumni association, serving
as chairman for his class

reunions. Giving many years
of service as a member of
the Exccutive Council and
its committees, he is cur
rently chairman of the
Annual Fund and a member
of the Eliot Society Member
ship Committee and the
Alumni Board of Governors.
Davidson is a respected
family phy sician and
cardiologist, often treating
several generations of the
same family. He takes
genuine pleasure in working
with students who find in
him a valued model and
mentor. Colleagues and
patients describe him with
su perlati ves: "tremendously
caring and thoughtful,"
"very conscientious and
hard-working," "very
dedicated to his patients, his
family and his community."

William M. Landau, M.D.
'47, is professor of neurol
ogy at the School of Medi
cine. From 1970 to 1991 he
was head of the department
of neurology, and from 1974
to 1991 also co-head of the
combined department of
neurology and neurological
surgery.
Landau is widely re
spected for his clinical
acumen and for his signifi
cant investigation of the
motor system, which has
been hi s abiding research
interest. He is internationally
known for his critical
analysis of neurological
research and for applying to
his own work the same
exacting standards. His
somewhat sa tirical papers on
"neuromythology" have been
said to express the scientific
conscience of neurology.
He is equally reputed
locally as an incisive critic
of political and social issues
and a spirited pm1icipant in
community affairs. He has
been admiringly character

ized as a person "who does
not shun battles and is
notorious for starting them,
if they involve causes about
which he has strong convic
tions."
His stature as a teacher
was honored by the senior
medical students with their
Teacher of the Year Award
in 1987.

Frederick D. Peterson,
M.D. '57, is assoc iate
professor of clinical pediat
rics at the School of Medi
cine and has maintained a
thriving private practice for
ove r 30 years.
Peterson is a clinical
faculty representative to the
Executive Faculty. He also
has been instrumental in
helping to establish the
Community Office Practice
Experience (COPE), which
has revolutionized the
manner in which ambulatory
pediatrics is taught to
residents by providing
training in the office of a
practicing pediatrician. He
gives generously of his time
and expertise to those he
teaches, and they especial Iy
value his ability to critique
in a way that is both effec
tive and kind .
Peterson is devoted to the
highest standards of patient
care and has made signifi
cant contributions to patient
care review. He has brought
skill and sensitivity to that
work, successfully negotiat
ing a variety of challenging
and difficult tasks.
To his many patients and
their parents Peterson is an
extraordinarily able and
beloved physician who
inspires confidence and trust.
His colleagues say he takes
his role as physician and
teacher very seriously, is
"articulate and tactful " and
"a joy to work with."

Distinguished
Service Award
Bernard Becker, M.D., is
professor and emeritus head
of the Department of
Ophthalmology at the School
of Medicine. He headed the
department from 1953 to
1988, becoming world
renowned for his research on
glallcoma. And he led the
department to an interna
tional reputation for excep
tional research and teaching.
Concurrently , he attained a
reputation as a supportive
leader who encouraged each
individual's professional
growth .
Becker is the co-author of
a classic text on glaucoma
diagnosis and therapy . His
publications include several
other books, book chapters
and hundreds of journal
articles. He was the first
editor-in-chief of the Journal
of Investigative Ophthalmol
ogy. He is the recipient of
several of the most presti
giolls awards in ophthalmol
ogy, both ill this country and
in Europe.
At Washington Univer
sity, Becker devoted many
hours of service as chair of
the Library Campa:gn
Steering Committee,
providing leadership for
planning and construction of
the new Library and Bio
medical Communications
Center.
Becker's influence has
been far-reaching . Described
by his friends as "quiet and
modest," his work has
benefitted many patients,
medical students, and
colleagues and has brought
honor to the School of
Medicine . •
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Ruth Moenster, assistallt to
the director of medicaL
alumni programs, greets
Philip Shahan, M.D. '42.
III the background is
HanfleLe HaapaLa, annuaL
fund director.

ALan L. Brodsky, M.D. '67, converses with
Mrs. Ira J. (Barbara) Kodner.

Reunion class gift chair W.
Edward Lansche, M.D. '52, with
his wife, Dee.

Mrs. David (Dee) Desper;
MicheLe Flicker, M.D. '76,
and David Desper, M.D.
'77.

I
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William A. Peck, M.D., vice
chancellor for medical affairs
and dean, presents the Distin
guished Service A ward to
Bernard Becker, M.D.

Mrs. Palll (Charlotte) Hagemann and PaulO. Hagemann,
M.D. '34, with Alulllni Achievement A ward recipient Harry
S. Jonas, M.D. '52.

William A. Abele, M.D. '47
(standing), visits with
Burnet W. Peden, M.D. '47;
Jack W. Newport, M.D. '47,
and Mrs. Jack (Patsy)
Newport.

Mrs. Robert (Sumn) Fry;
Robert Fry, M.D. '72 (reunion
class social chairman);
Kellneth J. Usberg, M.D. '72,
and Nancy Stengle.
31

Mrs. Philip (jean) Shahan and her husband, reunion class
social chairman Philip T. Shahan, M.D. '42, in conversation
with C. Barber Mueller, M.D. '42.
Eric William Friedrich, M.D.
'67, and Mrs. (Ann) Friedrich.

I. Jerome Flance, M.D. '35, who
won the AlumnilFawity A ward in
1990, shares his thoughts with John
D. Davidson, M.D. '52, who won
the same award this year. Davidson
also served as reunion class social
chairman.

Penelope G. Shacke(ford, M.D. '68,
incoming president of the Wash
ington University Medical Center
Alumni Association, speaking at
the banquet after accepting the
gavel.

William A. Peck, M.D., vice chancellor for
medical affairs and dean, in the company of
Washington University trustee Robert C.
Drews, M.D. '55, and Robert L. Virgil, Ph.D.,
executive vice chancellor for university
relations.
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Chancellor William H.
Danforth, M.D. , shares a
moment with Robert D.
Vtiger, M.D. '57, Alumni
Achievement Award
recipient.

Mrs. John M. (MoLLy)
Slaughter and John M.
Slaughter, M.D. '42.

Mrs. Helman (Evelyn)
Wasserman; Helman C.
Wasserman, M.D. '32; Gerald
Wool, M.D., '62, and Mrs.
Gerald (Sandra L.) Wool.
Wasserman served in the dual
role of both social and gift
chair for the 60th reunion
class.

J. Keller Mack, M.D. '32;
Mrs. Eugene (Margaret)
Bricker; Eugene M. Bricker,
M.D. '34, and Ruth Benjamin
enjoying the evening.
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Ira J. Kodner, M.D. '67,
president of WUMCAA,
presides at the alumni awards
banquet.

Ira J. Kodner, M.D. '67,
congratulates JOI/ Morris,
president of the class of '92,
following the official
welcome of graduating
students into the alumni
association

Randy L. Farmer, Ed.D. , assistant vice
chancellor and director for medical
alumni and development programs,
visiting with Mark H. Gregory, M.D.,
and Mrs. Mark (Patricia) Gregory,
Ph.D., director of corporate and
foundation relations in the Office of
Medical Alumni and Development.

Reunion class gift
chairman Gene H.
Grabau, M.D. '42,
responding for his
classmates after their
recognition at the
awards banquet. He
also welcomed the class
of '92 into the alulllni
association.
Beverly Logan-Morrison, M.D. '82, who served
as both social and gift chair for her reunion
class, renewing acquaintances with Karen L.
Goodlett, M.D. '82.
34

Mn. BirkLe (Mary Lea) Eck;
BirkLe Eck, M.D. '42; Mrs.
George Watkins; George
Watkins, M.D. '42; Mrs. Ewald
(Ort) Busse, and Ewald (Bud)
Busse, M.D. '42.
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Willialll M. Landau, M.D.
'47, recipient of the
Alumni/Faculty Award
and reunion class gift
chair, greets classmates.
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Robert Kingsland, M.D. '37, reunion class
chairman, and Mrs. (Shirley) Kingsland.

Photography enthusiast
George Sato, M.D. '47,
served as reunion class
sociaL chairman.
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Melrose Blackett, M.D. '82, and
Kellnistoll Carr, M.D. '82.
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Mrs. Raymond A. (AIlIl) Ritter; Raymolld A. Ritter, Jr., M.D. '62, (reU1liOIl
class social chair), and A/all Bisno, M.D. '62.
Mrs. Asa (Dorothy W.) JOlles alld Asa C.
JOlles, M.D. '42.

C. Barber Mueller, M.D. '42, alld Mrs. (Jean
M.) Mueller.

T1,e brothers Adler: Bellard c., M.D. '37, alld Morton W., M.D. '37,
eTljoying the reunion.

[I

36

Louis J. Novoa added a tOllch of personal style to his traditional
garb during commellcement exercises held Friday, May 15. The leis
were rUlllored to be symbolic of Novoa's impending marriage in the
Hawaiian Islands. The School of Medicine cOl~ferred IS M.D.lPh.D.
degrees, .five M.D.lM.A. degrees and 110 M.D. degrees.
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School of Medicine
Campus Box 8065
660 S. Euclid Ave .
St. LOllis, MO 63110-1093
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A diagram of what we call pai" shows that ollly the outermost layer of the
model- pain behavior - can be observed. But the complex process of
experiencing paill begins with the stimulatioll of nociceptor.\·, nerves dedicated
to sensillg painful stimuli. For more about pain and its management, see the
feature story in tltis issue.
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